Ed Zhang, MBA
Ed Zhang, MBA, serves as Co-founder and Interim CEO at Overland Pharmaceuticals, and Venture Partner, BioVenture at Hillhouse Capital.
Prior to Overland, Ed was VP of Corporate Development at Boston Pharmaceuticals, representing a new biotech business model focused on translational clinical development. As part of its founding team, Ed led corporate development and strategic initiatives including establishing partnerships with leading global pharma and biotech companies. Prior to joining Boston Pharma, Ed headed Global Business Development for Sanofi’s Renal Strategic Unit and was Director of Commercial Operations and Strategic Development at Genzyme before acquisition by Sanofi. Ed started his career as a medicinal chemist at Pharmacia & Upjohn and now brings over 17 years of biopharma industrial experience to Overland.
Ed holds an MBA from Kellogg School of Management at Northwestern University, an MS in chemistry from Binghamton University, and a BS from Nanjing University.